CA2601046A1 - Composition comprising isoorientin for suppressing histamine - Google Patents

Composition comprising isoorientin for suppressing histamine Download PDF

Info

Publication number
CA2601046A1
CA2601046A1 CA002601046A CA2601046A CA2601046A1 CA 2601046 A1 CA2601046 A1 CA 2601046A1 CA 002601046 A CA002601046 A CA 002601046A CA 2601046 A CA2601046 A CA 2601046A CA 2601046 A1 CA2601046 A1 CA 2601046A1
Authority
CA
Canada
Prior art keywords
isoorientin
extract
aloe
histamine
bamboo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002601046A
Other languages
English (en)
French (fr)
Inventor
Sung-Sick Woo
Dong-Seon Kim
Seon-Gil Do
Young-Chul Lee
Mi-Sun Oh
Ji-Min Cha
Tae-Hyung Jo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unigen Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2601046A1 publication Critical patent/CA2601046A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H39/00—Devices for locating or stimulating specific reflex points of the body for physical therapy, e.g. acupuncture
    • A61H39/04—Devices for pressing such points, e.g. Shiatsu or Acupressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/01—Constructive details
    • A61H2201/0157—Constructive details portable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/01—Constructive details
    • A61H2201/0192—Specific means for adjusting dimensions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/16—Physical interface with patient
    • A61H2201/1683—Surface of interface
    • A61H2201/169—Physical characteristics of the surface, e.g. material, relief, texture or indicia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2205/00—Devices for specific parts of the body
    • A61H2205/06—Arms
    • A61H2205/065—Hands
    • A61H2205/067—Fingers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Rehabilitation Therapy (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA002601046A 2005-03-18 2006-03-17 Composition comprising isoorientin for suppressing histamine Abandoned CA2601046A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2005-0022772 2005-03-18
KR1020050022772A KR100720973B1 (ko) 2005-03-18 2005-03-18 천연물 유래 아이소오리엔틴을 포함하는 히스타민 억제용약학 조성물
PCT/KR2006/000984 WO2006098603A2 (en) 2005-03-18 2006-03-17 Composition comprising isoorientin for suppressing histamine

Publications (1)

Publication Number Publication Date
CA2601046A1 true CA2601046A1 (en) 2006-09-21

Family

ID=36992143

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002601046A Abandoned CA2601046A1 (en) 2005-03-18 2006-03-17 Composition comprising isoorientin for suppressing histamine

Country Status (9)

Country Link
US (1) US20080214658A1 (enExample)
EP (1) EP1863498A2 (enExample)
JP (1) JP2008533131A (enExample)
KR (1) KR100720973B1 (enExample)
CN (1) CN101203228A (enExample)
AU (1) AU2006223734B2 (enExample)
BR (1) BRPI0608546A2 (enExample)
CA (1) CA2601046A1 (enExample)
WO (1) WO2006098603A2 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7108868B2 (en) 2002-03-22 2006-09-19 Unigen Pharmaceuticals, Inc. Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
US8034387B2 (en) 2002-04-30 2011-10-11 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
CN100544715C (zh) 2002-04-30 2009-09-30 尤尼根制药公司 作为治疗剂的包含无取代b环类黄酮和黄烷混合物的组合物
JP4684893B2 (ja) * 2003-03-27 2011-05-18 ユニジェン インク． 炎症性及び血液循環疾患の治療及び予防活性を示す、竹抽出物並びにそれから分離された化合物を含有する組成物
WO2004089392A1 (en) 2003-04-04 2004-10-21 Unigen Pharmaceuticals, Inc. Formulation of dual cycloxygenase (cox) and lipoxygenase (lox) inhibitors for mammal skin care
KR100720971B1 (ko) * 2004-06-11 2007-05-22 주식회사 유니젠 대나무 또는 대나무 추출물을 포함하는 안드로젠 효능성조성물
JP2007045755A (ja) * 2005-08-10 2007-02-22 Kameda Seika Co Ltd 美白剤、抗アレルギー剤及び食料品
KR100761248B1 (ko) 2006-10-12 2007-10-04 주식회사 유니젠 대나무 및 황금 추출물을 유효성분으로 함유하는 아토피성피부염 치료를 위한 조성물
KR101050129B1 (ko) * 2008-06-18 2011-07-19 주식회사 한국인삼공사 알레르기 질환 예방 또는 치료용 조성물
KR101702056B1 (ko) * 2009-11-16 2017-02-03 주식회사 유니베라 피부세포증식 촉진, 항산화 및 항알러지 효과가 우수한 알로에 베라 새순 농축물 또는 추출물
FR2956324A1 (fr) * 2010-01-18 2011-08-19 Valerie Baille Complexe vegetal comprenant un extrait polyphenolique de bambou
CN101843612B (zh) * 2010-05-21 2012-01-11 暨南大学 异荭草苷作为制备抗呼吸道合胞病毒的药物的用途
CN102285976A (zh) * 2011-09-27 2011-12-21 天津市尖峰天然产物研究开发有限公司 从竹叶黄酮中提取异荭草素的方法
CN102743375A (zh) * 2012-04-28 2012-10-24 苏州凯祥生物科技有限公司 异荭草素的用途及其药物组合物
KR20150019505A (ko) * 2013-08-14 2015-02-25 대화제약 주식회사 플라본-6-c-글루코스 유도체를 유효성분으로 함유하는 신경정신질환의 치료 또는 예방용 약학적 조성물
KR102488562B1 (ko) * 2020-11-02 2023-01-12 인천대학교 산학협력단 갯끈풀 추출물을 유효성분으로 포함하는 염증 또는 아토피 피부염의 개선, 예방 또는 치료용 조성물
WO2022250313A1 (ko) * 2021-05-27 2022-12-01 주식회사 유니베라 알로에 베라 꽃 추출물, 또는 알로에 베라 꽃 추출물 및 알로에 베라 다당체를 유효성분으로 함유하는 피부 보습, 재생 촉진 및 상처 치료용 조성물
KR102543123B1 (ko) * 2021-05-27 2023-06-13 주식회사 유니베라 알로에 꽃 추출물을 유효성분으로 함유하는 피부 보습용 조성물
CN116349706B (zh) * 2021-12-27 2025-06-17 中国科学院植物研究所 水稻叶片提取物在杀虫中的应用
CN116349698B (zh) * 2021-12-27 2025-06-17 中国科学院植物研究所 水稻叶片提取物在抑制植物生长中的应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201776A (en) * 1977-01-31 1980-05-06 The Green Cross Corporation Food additive for reinforcing foods deficient in fiber content
US5106616A (en) * 1988-01-14 1992-04-21 Carrington Laboratories, Inc. Administration of acemannan
US5308838A (en) * 1982-05-07 1994-05-03 Carrington Laboratories, Inc. Uses of aloe products
JPS61233627A (ja) * 1985-04-10 1986-10-17 Agency Of Ind Science & Technol 肥満細胞脱顆粒抑制剤
US5098709A (en) * 1987-07-21 1992-03-24 Kang Kwon J Method of administrating a fused salt from natural substances, namely ginkgo, persimmon, pine, and bamboo in the treatment of inflammations
JPH05271088A (ja) * 1991-12-27 1993-10-19 Ruibosuteii Japan:Kk 皮膚疾患・免疫反応による組織障害改善治療剤
JPH05271090A (ja) * 1991-12-27 1993-10-19 Ruibosuteii Japan:Kk 活性酸素消去・除去剤
JPH06199690A (ja) * 1992-03-06 1994-07-19 Yunie:Kk 脳代謝促進・脳機能改善剤
JP3811198B2 (ja) * 1993-11-17 2006-08-16 株式会社創研 米からの抗アレルギー剤
TW235922B (en) * 1994-07-06 1994-12-11 Amboo Devise Co Ltd A production process of deodorant
JPH0840923A (ja) * 1994-07-28 1996-02-13 Masatoshi Nakano 栄養補助剤
JPH1171292A (ja) 1997-08-29 1999-03-16 Masatoshi Nakano 皮膚外用剤
HK1038700A1 (zh) * 1999-07-23 2002-03-28 E-L Management Corp. 含有含羞草属酚类化合物的组合物
AU2001246876A1 (en) * 2000-04-10 2001-10-23 Takara Bio Inc. Remedies
AU2001246877A1 (en) * 2000-04-11 2001-10-23 Takara Bio Inc. Remedies
US20030170186A1 (en) * 2000-04-18 2003-09-11 Bernadette Geers Novel flavone glycoside derivatives for use in cosmetics, pharmaceuticals and nutrition
US20020146467A1 (en) * 2001-02-08 2002-10-10 Jung Kyu Yong Herbal composition for the prevention and treatment of dementia
US20040185124A1 (en) * 2002-10-24 2004-09-23 Hiromichi Hayashi Health food and antitumor agent
US20030125264A1 (en) * 2001-12-29 2003-07-03 Kimberly-Clark Worldwide, Inc. Methods For Treating Wounds
JP2003212786A (ja) * 2002-01-16 2003-07-30 Univ Nihon 竹の抽出成分を有効成分とする皮膚外用薬
JP4684893B2 (ja) * 2003-03-27 2011-05-18 ユニジェン インク． 炎症性及び血液循環疾患の治療及び予防活性を示す、竹抽出物並びにそれから分離された化合物を含有する組成物
CN1528197A (zh) * 2003-10-08 2004-09-15 ƽ 竹叶抗氧化物及其用途
US7678920B2 (en) * 2004-04-08 2010-03-16 Dow Agrosciences Llc Insecticidal N-substituted sulfoximines
KR100720971B1 (ko) * 2004-06-11 2007-05-22 주식회사 유니젠 대나무 또는 대나무 추출물을 포함하는 안드로젠 효능성조성물
KR100761248B1 (ko) * 2006-10-12 2007-10-04 주식회사 유니젠 대나무 및 황금 추출물을 유효성분으로 함유하는 아토피성피부염 치료를 위한 조성물

Also Published As

Publication number Publication date
WO2006098603A2 (en) 2006-09-21
AU2006223734B2 (en) 2012-03-29
AU2006223734A1 (en) 2006-09-21
CN101203228A (zh) 2008-06-18
BRPI0608546A2 (pt) 2010-11-16
US20080214658A1 (en) 2008-09-04
EP1863498A2 (en) 2007-12-12
KR20070039406A (ko) 2007-04-12
JP2008533131A (ja) 2008-08-21
KR100720973B1 (ko) 2007-05-22
WO2006098603A3 (en) 2006-11-30

Similar Documents

Publication Publication Date Title
AU2006223734B2 (en) Composition comprising isoorientin for suppressing histamine
JP2021522261A (ja) カンナビジオール製剤及びその使用
EP3062802B1 (en) Extracts from moringa oleifera and methods of making
CA2455425C (en) Water soluble extract from plant of solanum genus and the preparation process thereof, and pharmaceutical composition containing the water soluble extract
WO2010073404A1 (ja) カシューアップルのプロアントシアニジン、プロアントシアニジン含有組成物、およびその用途
TWI890136B (zh) 反式-3-吲哚丙烯酸及4-葡萄糖基香草酸用於製備減脂的組合物之用途以及減脂組合物
CN110167571A (zh) 5型磷酸二酯酶活性抑制用组合物
EP2805722B1 (en) Desrhamnosylacteoside-containing olive extract
AU2016244997B2 (en) Extracts from plants of the Moringaceae family and methods of making
EP3639817B1 (en) Compositions containing pterosin compound and derivatives thereof active ingredients for prevention or treatment of degenerative brain diseases
EP1854446B1 (en) Cold-water hop extract for use in prevention or alleviation of the symptoms of an allergic disease
EP2152283A1 (en) Water soluble opuntia extracts for the inhibition of alpha-1-adrenergic receptors
KR20150020466A (ko) 천년초 열매 추출물을 유효성분으로 포함하는 항염증용 조성물
KR101982657B1 (ko) 테트라세라 로우레이리 추출물을 이용한 항염증용 조성물
KR102535526B1 (ko) 벌개미취에서 분리된 신규한 화합물
KR101418164B1 (ko) 자외선을 처리한 벼 추출물을 유효성분으로 포함하는 대장암 예방 또는 치료용 약학적 조성물
US7357951B2 (en) Composition for preventing atherosclerosis
KR102040527B1 (ko) 람노시트린을 이용한 항염증용 조성물
EP1508334B1 (en) Water soluble extract from plant of solanum genus and the preparation process thereof, and pharmaceutical composition containing the water soluble extract
JP5591122B2 (ja) カシューアップルのプロアントシアニジン、プロアントシアニジン含有組成物、およびその用途
KR101935471B1 (ko) 괭생이모자반 효소 처리물을 이용한 항염증용 조성물
EP4653006A1 (en) Novel mixture of active ingredients, compositions containing them, and their use against allergy and/or inflammation
KR20250171747A (ko) 김네마 이노도룸 (Gymnema inodorum) 추출물 또는 이로부터 분리한 화합물을 유효성분으로 포함하는 근육질환 예방 또는 치료용 조성물
JP5976025B2 (ja) ヒアルロン酸合成促進剤の製造方法、ヒアルロン酸合成促進剤、ＨＡＳ２ｍＲＮＡ発現促進剤の製造方法及びＨＡＳ２ｍＲＮＡ発現促進剤

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20130225